Pub. Date : 2020 Feb 17
PMID : 32066489
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | BACKGROUND: Ticagrelor is a reversibly binding, direct-acting, oral, P2Y12 antagonist used for the prevention of atherothrombotic events in patients with coronary artery disease (CAD). | ticagrelor | purinergic receptor P2Y12 | Homo sapiens |
| 2 | Ticagrelor blocks adenosine reuptake through the inhibition of equilibrative nucleoside transporter 1 (ENT-1) on erythrocytes and platelets, thereby facilitating adenosine-induced physiological responses such as an increase in coronary blood flow velocity. | ticagrelor | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 3 | Ticagrelor blocks adenosine reuptake through the inhibition of equilibrative nucleoside transporter 1 (ENT-1) on erythrocytes and platelets, thereby facilitating adenosine-induced physiological responses such as an increase in coronary blood flow velocity. | ticagrelor | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |